Brief: Ambu Reports Q3 EBIT DKK 221 Mln
26/08/2026 07:39
BRIEF-Ambu Reports Q3 EBIT DKK 221 Mln Aug 26 (Reuters) - Ambu A/S AMBUb.CO:
SAID ON TUESDAY Q3 REVENUE DKK 1.64 BLN
Q3 EBIT DKK 221 MLN
Q3 EBIT MARGIN 13.5%
Q3 ENDOSCOPY SOLUTIONS ORGANIC GROWTH 16.0%
Q3 RESPIRATORY ORGANIC GROWTH 17.1% (11.2%)
Q3 UROLOGY, ENT & GI ORGANIC GROWTH 15.0%
Q3 ANESTHESIA & PATIENT MONITORING ORGANIC GROWTH 1.6%
Source text: Link
Further company coverage: [AMBUb.CO]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Ambu A/S
See all newsBrief: Ambu Says Two Bronchoscopes Get FDA Clearance, CE Mark For Use In Pediatric Airway Procedures
Brief: Ambu Obtains Regulatory Clearances For Expanded GI Indication
UBS turns cautious on Ambu's targets, cuts to 'neutral'
Brief: Ambu Acquires TIMS Medical To Advance Endointelligence
Brief: Ambu Reports Q3 EBIT DKK 221 Mln